IBTA heads into its August 3 earnings date with a fresh Goldman Sachs target cut, active CEO selling, and one of the highest short scores in its peer group — a cluster of bearish signals that the stock's modest month-to-date recovery has done little to dislodge.
The most immediate catalyst is Goldman. Eric Sheridan trimmed his price target on IBTA to $28 from $32 on July 8 — this week — maintaining his Sell rating. That move is notable for two reasons: it came just days before the next earnings print, and it brings Goldman's target 16% below the current $33.47 price. The broader analyst picture is divided. Needham holds a $45 Buy, and Evercore and Wells Fargo lifted targets meaningfully in May after the Q1 print. But Goldman and BofA both have below-market targets with Sell and Underperform ratings respectively, and the consensus mean target of $33.43 is essentially flat to the current price — offering no implied upside in aggregate. The Street's bull case rests on the performance marketing flywheel expanding to new publishers and general merchandise. The bear case is blunter: 2026 revenue growth now expected to be flat versus a prior 19% guide, and a salesforce reorganisation that has dragged affected accounts' revenues down by 16%.
Insider activity adds another bearish data point to the mix. CEO and founder Bryan Leach sold shares on both July 1 and July 2, with the combined July 1 transactions alone worth over $525,000 at prices around $35. CTO Luke Swanson also sold on July 1. These are relatively small parcels relative to Leach's 13.2% stake, and the 90-day net is positive at roughly $3.96 million in net proceeds — reflecting ongoing plan-based selling rather than a sudden exit. Still, insiders have been consistent sellers into any price strength, and the current price is already below those July transaction prices.
Short positioning tells a high-conviction story. Short interest has edged lower over the past month, down about 4% in shares terms, but it remains elevated at 12.4% of free float — a level ORTEX flags as "high." The ORTEX short score has been locked in a narrow band around 83-84 for the past two weeks, placing IBTA in the top 1% of the universe for short-score rank. Borrowing costs have eased sharply — cost-to-borrow dropped more than 40% on the week to just 0.61%, the lowest in over a month — and availability has opened up to around 70%, after touching the tighter end of the range (below 50%) on several days in June. That loosening borrow market suggests short sellers are not under squeeze pressure; if anything, it reflects a stable or gently declining short base rather than a forced unwind.
Options positioning meanwhile has shifted in the opposite direction — away from defensiveness and toward call-side exposure. The put/call ratio has collapsed to just 0.16, near its 52-week low of 0.156 and well below its 20-day average of 0.20. That skew toward calls stands in contrast to the short interest picture, where institutional pessimism is still embedded. It may reflect retail or event-driven positioning ahead of the August 3 print rather than a structural view, but the divergence between a heavy short book and a call-heavy options market is the defining tension in IBTA's setup right now.
The earnings history adds relevant texture. The last three results produced a 3.8% one-day gain in May 2026, an 8.7% one-day loss in February 2026, and a roughly flat open the prior quarter. Five-day reactions have been more volatile, with one episode producing a 12% drawdown over the week after the print. With Goldman cutting its target the week before the release and the consensus offering zero implied upside, the August 3 print becomes the next clear test of whether the growth deceleration narrative has been fully priced in — or still has room to reset.
See the live data behind this article on ORTEX.
Open IBTA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
